Tabalumab (Anti-TNFSF13B / BAFF / CD257) is a humanised monoclonal antibody BAFF (B-cell activating factor). It can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus. MW :146.2 KD.